Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JEFFREY R LISH

Allopathic & Osteopathic Physicians Family Medicine

NPI
1003848797
CMS profile
1103752
Location
BRIGHAM CITY, UT

General Payments · PY2018–2024

$4,200.41

  • Reported across 318 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$541.78

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $541.78 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $133.48 12
Amgen Inc. $69.12 4
Astellas Pharma US Inc $57.22 3
Indivior Inc. $43.42 2
GlaxoSmithKline, LLC. $40.21 2
DEXCOM, INC. $34.55 2
Lilly USA, LLC $33.87 2
Acerta Pharma LLC $33.37 2
NOVARTIS PHARMACEUTICALS CORPORATION $25.15 1
Inspire Medical Systems, Inc. $18.89 1
BOSTON SCIENTIFIC CORPORATION $18.16 1
Novo Nordisk AS $17.29 1
Organon LLC $17.05 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $706.51 64
PY2019 $440.86 30
PY2020 $733.54 52
PY2021 $769.65 60
PY2022 $472.86 38
PY2023 $535.21 39
PY2024 $541.78 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $3.53 01/29/2024 Food and Beverage Undisputed 01/23/2026 1104888957 CMS
ABBVIE INC. $14.20 04/10/2024 Food and Beverage Undisputed 01/23/2026 1104888959 CMS
ABBVIE INC. $9.47 05/07/2024 Food and Beverage Undisputed 01/23/2026 1104888961 CMS
ABBVIE INC. $5.41 05/21/2024 Food and Beverage Undisputed 01/23/2026 1104888963 CMS
ABBVIE INC. $30.00 05/28/2024 Food and Beverage Undisputed 01/23/2026 1104888965 CMS
ABBVIE INC. $7.99 07/23/2024 Food and Beverage Undisputed 01/23/2026 1104888967 CMS
ABBVIE INC. $1.67 07/31/2024 Food and Beverage Undisputed 01/23/2026 1104888969 CMS
ABBVIE INC. $23.27 08/22/2024 Food and Beverage Undisputed 01/23/2026 1104888971 CMS
ABBVIE INC. $13.48 10/15/2024 Food and Beverage Undisputed 01/23/2026 1104888973 CMS
ABBVIE INC. $7.57 10/22/2024 Food and Beverage Undisputed 01/23/2026 1104888975 CMS
ABBVIE INC. $9.46 11/05/2024 Food and Beverage Undisputed 01/23/2026 1104888977 CMS
ABBVIE INC. $7.43 12/11/2024 Food and Beverage Undisputed 01/23/2026 1104888979 CMS
Amgen Inc. $14.43 02/06/2024 Food and Beverage Undisputed 01/23/2026 1111635966 CMS
Amgen Inc. $13.33 02/28/2024 Food and Beverage Undisputed 01/23/2026 1111635968 CMS
Amgen Inc. $18.81 05/09/2024 Food and Beverage Undisputed 01/23/2026 1117311740 CMS
Amgen Inc. $22.55 09/06/2024 Food and Beverage Undisputed 01/23/2026 1117311742 CMS
Astellas Pharma US Inc $18.91 01/17/2024 Food and Beverage Undisputed 01/23/2026 1139290272 CMS
Astellas Pharma US Inc $18.68 04/08/2024 Food and Beverage Undisputed 01/23/2026 1139324276 CMS
Astellas Pharma US Inc $19.63 08/01/2024 Food and Beverage Undisputed 01/23/2026 1139374497 CMS
AstraZeneca Pharmaceuticals LP $16.68 01/17/2024 Food and Beverage Undisputed 01/23/2026 1104452894 CMS
AstraZeneca Pharmaceuticals LP $16.69 01/18/2024 Food and Beverage Undisputed 01/23/2026 1105743610 CMS
Boston Scientific Corporation $18.16 06/19/2024 Food and Beverage Undisputed 01/23/2026 1092663883 CMS
Dexcom, Inc. $15.74 01/11/2024 Food and Beverage Undisputed 01/23/2026 1153307661 CMS
Dexcom, Inc. $18.81 08/23/2024 Food and Beverage Undisputed 01/23/2026 1153307663 CMS
GlaxoSmithKline, LLC. $22.14 09/24/2024 Food and Beverage Undisputed 01/23/2026 1116052409 CMS
GlaxoSmithKline, LLC. $18.07 12/11/2024 Food and Beverage Undisputed 01/23/2026 1116248513 CMS
Indivior Inc. $21.02 07/31/2024 Food and Beverage Undisputed 01/23/2026 1144532376 CMS
Indivior Inc. $22.40 09/30/2024 Food and Beverage Undisputed 01/23/2026 1144532378 CMS
Inspire Medical Systems, Inc. $18.89 01/15/2024 Food and Beverage Undisputed 01/23/2026 1148074650 CMS
Lilly USA, LLC $19.27 04/29/2024 Food and Beverage Undisputed 01/23/2026 1135011973 CMS
Lilly USA, LLC $14.60 09/16/2024 Food and Beverage Undisputed 01/23/2026 1135040051 CMS
Novartis Pharmaceuticals Corporation $25.15 11/20/2024 Food and Beverage Undisputed 01/23/2026 1087112324 CMS
Novo Nordisk Inc $17.29 06/28/2024 Food and Beverage Undisputed 01/23/2026 1097312982 CMS
Organon Llc $9.85 04/18/2024 Food and Beverage Undisputed 01/23/2026 1136213650 CMS
Organon Llc $7.20 08/21/2024 Food and Beverage Undisputed 01/23/2026 1136213648 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.